Michael Mullan

Who is Michael Mullan?

Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer's disease. Mike Mullan's Alzheimer research is well known among the Biomedical Community. Dr. Mullan's Alzheimer research work resulted in identifying the most widely known Swedish Mutation that is present in familial form. Transgenic Animal models for Alzheimer Disease frequently use the Swedish Mutation.

Dr. Mullan is a recognized authority on Alzheimer's disease and related disorders. Dr. Michael Mullan was trained as a physician in England receiving his medical degree from London University. He subsequently gained a PhD in molecular genetics, also from London University. He is an inventor on the patents covering the first ever genetic mutations linked to familial Alzheimer's disease. He was an author and senior author on the first papers describing the genetic errors which cause early onset familial Alzheimer's disease. He has co-authored over 200 papers on Alzheimer's disease and related disorders—on many of which he served as senior author. He has held positions a Professorial Chair and positions as professor of Psychiatry, Neurology, and Pathology.